Biolight Life Sciences Ltd
TASE:BOLT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Biolight Life Sciences Ltd (BOLT) under the Base Case is ILS per share. Compared with the current market price of 301.5 ILS, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Biolight Life Sciences Does
BioLight Life Sciences Ltd. engages in the management, research and development, investments or sale of solutions, the purpose of which is to address a real need that exists in the field of eye diseases. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The firm provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property.
- Headquarters
- Israel IL
- IPO date
- Dec 27, 2005
Balance Sheet
Continue BOLT Research
Decided on Biolight Life Sciences? Get an email when BOLT reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one BOLT stock?
The intrinsic value for Biolight Life Sciences Ltd (BOLT) under the Base Case is ILS.
Is BOLT stock undervalued or overvalued?
Compared with the current market price of 301.5 ILS, the stock appears .